Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN16851495) titled 'Effects of OPTIMEALTH FOOD on gut health' on May 19.
Study Type: Interventional
Study Design:
Interventional double-blind placebo-controlled single-center randomized clinical trial (Quality of life)
Primary Sponsor: INNOVATION LABO SCIENCES Co., Ltd
Condition:
Constipation
Digestive System
Intervention:
This study investigates 4 weeks of daily supplementation with Optimealth Food (300 mg/day, 150 mg x 2 capsules) or a placebo (dextrin, 300 mg/day, 150 mg x 2 capsules) taken orally at breakfast. Block randomization was used to allocate participants to each group.
Block randomization is used to divide potenti...